In NSCLC, upregulation of NCAPD3 promotes tumor growth via the MEK/ERK/LDHA signaling axis, with histone lactylation enhancing NCAPD3 expression and amplifying glycolysis and malignant phenotypes [181]. Here, NCAPD3 is linked to non-small cell lung carcinoma.